Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis. Leuk Res. 2019;81:1-9..
Dacetuzumab plus R-ICE as salvage therapy for patients with DLBCL relapsing after R-CHOP: a randomized, double-blind, placebo-controlled Phase 2b trial. Leuk Lymphoma. 2015:1-24.
Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation. Bone Marrow Res. 2013;2013:658371..
Hodgkin Lymphoma: 2020 update on diagnosis, risk-stratification, and management. Am J Hematol. 2020..
Immunologic Autograft Engineering and Survival in Non-Hodgkin's Lymphoma. Biol Blood Marrow Transplant. 2016.